• Ep 6 - Dengue, and the Future of DNDi

  • Jun 10 2022
  • Length: 44 mins
  • Podcast

Ep 6 - Dengue, and the Future of DNDi

Listen for free

View show details

  • Summary

  • No existing medicine can defeat dengue. It’s one of the top ten threats to global public health, and as the effects of global warming begin to bite, the stage is set for its spread outward from the tropics. This looks like a job for medicine makers without borders, doesn’t it? Here to walk us through DNDi’s opening gambit against this neglected, climate-sensitive disease are Panisadee Avirutnan of Mahidol University and the DNDi’s own Isebela Ribeiro. Is there an open source path to victory here? Can the nonprofit model stop dengue in its tracks?

    Panisadee Avirutnan is an Associate Professor in the Department of Immunology at Mahidol University in Bangkok.

    Isabela Ribeiro is the Director of DNDi’s Viral Diseases Cluster.

    Mentioned in the episode

    the rise of dengue in Southeast Asia
    South-South leadership and cooperation
    the four serotypes of dengue

    Read more from the sharpest minds in pharma at 
    themedicinemaker.com

    If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at angus.stewart@texerepublishing.com
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Ep 6 - Dengue, and the Future of DNDi

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available